Skip to content

The Impact of Exercise During Pregnancy on Maternal and Infant Outcomes: A Randomized Controlled Trial

The Impact of Exercise During Pregnancy on Maternal and Infant Outcomes: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124142
Enrollment
Unknown
Registered
2026-05-08
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Dysfunction

Interventions

Experimental group :The experimental group of pregnant women underwent a moderate-to-low intensity aerobic exercise intervention three times a week, lasting 60 minutes each session.
Control group:Pregnant women in the control group received routine prenatal care and health lifestyle advice at their maternity care hospitals .

Sponsors

Guangdong Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.pregnant women aged 18–45 years; 2.singleton pregnancy; 3.gestational age of 8–12 weeks; 4.absence of severe pregnancy complications or comorbidities; 5.no absolute contraindications to exercise; 6.not participating in any other scientific research; 7.scheduled to deliver at Guangdong Maternal and Child Health Hospital; 8.capable of conducting basic communication in Chinese.

Exclusion criteria

Exclusion criteria: 1.Patients undergoing in vitro fertilization (IVF), twin or multiple pregnancies, those with absolute or relative contraindications to exercise during pregnancy, individuals diagnosed with mental disorders such as anxiety disorder or depression prior to pregnancy; or those expected to be unable to complete follow-up visits (e.g., those planning to deliver outside their local area). 2.Absolute contraindications for exercise during pregnancy include: severe cardiac or respiratory diseases, severe preeclampsia/eclampsia, uncontrolled hypertension, severe thyroid disorders, uncontrolled type 1 diabetes mellitus, premature rupture of membranes, threatened preterm labor, persistent vaginal bleeding of unknown cause, placenta previa after 28 weeks of gestation, cervical insufficiency, severe anemia, fetal growth restriction, and multiple pregnancies (three or more fetuses). 3.Relative contraindications for exercise during pregnancy include: mild to moderate cardiac or respiratory diseases, history of recurrent miscarriage or preterm birth, and severe pathological obesity (BMI >= 35 kg/m^2).2Or combined metabolic abnormalities), malnutrition, or extremely low body weight (BMI <12 kg/m^2).2), twin pregnancies after 28 weeks of gestation, and unstable epilepsy conditions; absolute or relative exercise contraindications during pregnancy (e.g., severe anemia, hypertension, fetal growth restriction, extremely high/low BMI, epilepsy, hyperthyroidism, or prolonged sedentary behavior in pregnant women, requiring cautious exercise under medical evaluation); patients diagnosed with mental disorders such as anxiety or depression before pregnancy; and those expected to be unable to complete follow-up visits (e.g., those planning to deliver outside their local area).

Design outcomes

Primary

MeasureTime frame
Pelvic Floor Surface Electromyography Assessment;Three-dimensional Pelvic Floor Ultrasound;POP-Q staging assessment;Manual evaluation of pelvic floor muscle strength;Incidence of postpartum anxiety and depression;Incidence of pelvic floor dysfunction during pregnancy and postpartum;

Secondary

MeasureTime frame
Measurement of four lipid parameter;C-reactive protein, CRP;Placenta-Derived Mesenchymal Stem Cells;Umbilical artery S/D ratio;Infant and early childhood developmental behavior;

Countries

China

Contacts

Public ContactYao Linlin

Guangdong Women and Children Hospital

85666441@qq.com+86 137 6063 5070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026